KB Medical Group — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

KB Medical Group is a established, commercial-stage private company and a global manufacturer of safety medical devices. Its core expertise lies in developing products with integrated safety features, such as its push-button blood collection sets and ENFit enteral connectors, aimed at reducing sharps injuries and misconnection risks. Supported by over 700 employees, a large manufacturing footprint, and regulatory approvals (FDA, CE, ISO 13485), the company serves a worldwide distributor network. Its product portfolio addresses multiple therapeutic areas including diabetes care, oncology, nutrition therapy, and anesthesia.

DiabetesOncologyNutritional SupportAnesthesia & Pain ManagementGeneral Medicine

Technology Platform

Integrated safety mechanisms for medical devices, including one-handed push-button needle safety, ISO 80369-3 compliant connectors (ENFit), and closed-system drug transfer designs.

Opportunities

The global, mandated transition to ISO 80369-3 (ENFit) connectors for enteral nutrition creates a large, time-bound replacement market.

Furthermore, increasing regulatory emphasis on healthcare worker safety in emerging markets presents a significant geographic expansion opportunity for its core safety device portfolio.

Risk Factors

The company faces intense competition from large, well-capitalized multinational medical device corporations, which could pressure margins and market share.

Additionally, its vertically integrated model exposes it to supply chain disruptions and raw material cost volatility, while its growth is partly dependent on the pace of hospital adoption of new connector standards.

Competitive Landscape

KB Medical competes in the crowded medical disposables market against giants like Becton Dickinson, Cardinal Health, and Fresenius Kabi, as well as numerous other specialized manufacturers. Its differentiation lies in a focused portfolio of safety-engineered devices, particularly in blood collection and ENFit-compliant nutrition products, but it must constantly innovate to defend its niche against larger players' broader portfolios and sales reach.

More companies in Oncology (General) →More companies in United States →